Oak Street Health Inc. [NYSE: OSH] loss -0.56% on the last trading session, reaching $35.23 price per share at the time. The company report on February 8, 2023 that CVS Health to Acquire Oak Street Health.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Acquisition further advances CVS Health’s care delivery strategy for consumers.
CVS Health® (NYSE: CVS) and Oak Street Health (NYSE: OSH) have entered into a definitive agreement under which CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.
Oak Street Health Inc. represents 231.92 million in outstanding shares, while the company has a total market value of $8.56 billion with the latest information. OSH stock price has been found in the range of $35.11 to $35.48.
If compared to the average trading volume of 4.37M shares, OSH reached a trading volume of 5351588 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Oak Street Health Inc. [OSH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OSH shares is $36.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OSH stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Oak Street Health Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on January 12, 2023. The new note on the price target was released on November 21, 2022, representing the official price target for Oak Street Health Inc. stock. On September 12, 2022, analysts decreased their price target for OSH shares from 32 to 29.
The Average True Range (ATR) for Oak Street Health Inc. is set at 1.00, with the Price to Sales ratio for OSH stock in the period of the last 12 months amounting to 4.33.
Trading performance analysis for OSH stock
Oak Street Health Inc. [OSH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.62. With this latest performance, OSH shares gained by 21.07% in over the last four-week period, additionally plugging by 21.19% over the last 6 months – not to mention a rise of 134.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OSH stock in for the last two-week period is set at 69.19, with the RSI for the last a single of trading hit 69.09, and the three-weeks RSI is set at 67.86 for Oak Street Health Inc. [OSH]. The present Moving Average for the last 50 days of trading for this stock 27.89, while it was recorded at 35.40 for the last single week of trading, and 23.79 for the last 200 days.
Oak Street Health Inc. [OSH]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Oak Street Health Inc. [OSH] shares currently have an operating margin of -29.15 and a Gross Margin at +0.59. Oak Street Health Inc.’s Net Margin is presently recorded at -28.58.
Return on Equity for this stock declined to -175.11, with Return on Assets sitting at -31.23.
Oak Street Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.60.
Oak Street Health Inc. [OSH]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OSH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Oak Street Health Inc. go to 30.00%.
An analysis of insider ownership at Oak Street Health Inc. [OSH]
There are presently around $8,055 million, or 99.00% of OSH stock, in the hands of institutional investors. The top three institutional holders of OSH stocks are: GENERAL ATLANTIC, L.P. with ownership of 61,384,475, which is approximately 0% of the company’s market cap and around 4.80% of the total institutional ownership; NEWLIGHT PARTNERS LP, holding 32,550,265 shares of the stock with an approximate value of $1.15 billion in OSH stocks shares; and FMR LLC, currently with $857.4 million in OSH stock with ownership of nearly -3.934% of the company’s market capitalization.
Positions in Oak Street Health Inc. stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 117 institutional holders increased their position in Oak Street Health Inc. [NYSE:OSH] by around 14,764,168 shares. Additionally, 119 investors decreased positions by around 9,835,463 shares, while 34 investors held positions by with 204,039,206 shares. The mentioned changes placed institutional holdings at 228,638,837 shares, according to the latest SEC report filing. OSH stock had 46 new institutional investments in for a total of 1,406,918 shares, while 42 institutional investors sold positions of 3,688,293 shares during the same period.